Skip to content
The Placebo Effect Can Still Work Even When You Know It's a Placebo
Discovery

Edited by Alex Surfaced·Psychology·3 min read
Share:

Groundbreaking research, prominently led by Harvard Medical School's Ted Kaptchuk and his team at Beth Israel Deaconess Medical Center, demonstrates that the placebo effect can still be remarkably effective even when patients are fully aware they are receiving an inert substance. In multiple randomized controlled trials, patients with conditions like irritable bowel syndrome (IBS) who received 'open-label placebos' (OLP) — explicitly labeled as sugar pills with no active drug — reported significant improvements, such as a 30% reduction in symptom severity compared to a no-treatment control group. This methodology involves transparently informing patients that they are taking a placebo but emphasizing the body's natural self-healing capacity. This surprising outcome challenges the long-held belief that deception is a prerequisite for the placebo effect, suggesting that the ritual of care and conscious expectation of relief are primary drivers, with studies often published in journals like PLOS One and Pain since the early 2010s.

Source linkedContext summarizedPsychology

Editorial check

How this page is checked

Source:ncbi.nlm.nih.gov

Source trail

ncbi.nlm.nih.gov

External links are separated from Surfaced commentary.

Reader safety

Context before clicks

Product links and external services are not presented as guarantees.

Monetization

No affiliate flag

Ads and commerce links are kept distinct from editorial text.

Surfaced take

Why It’s Fascinating

Experts were initially surprised because the prevailing understanding of the placebo effect hinged on an element of deception or blind faith in an active treatment. This research overturns the fundamental assumption that patients must be unaware they are receiving a placebo for it to work, shifting the focus from 'belief in the drug' to 'belief in the process of healing.' Within 5-10 years, this could lead to the ethical integration of open-label placebos into clinical care for chronic, symptom-based conditions like IBS, chronic pain, and fatigue, potentially reducing reliance on pharmacological interventions and empowering patients in their self-management. It's like a sports coach telling an athlete, 'This warm-up drill is just for preparation, but if you focus and commit, you'll still improve your form and feel better.' Patients suffering from chronic, often intractable conditions, and healthcare providers seeking non-pharmacological alternatives, stand to benefit most. This raises a profound thought-provoking question: If conscious expectation and the therapeutic ritual alone can trigger healing, what are the full, untapped potentials of the mind-body connection that we are yet to harness? This contrasts sharply with the 'pure placebo' model, where the effect is thought to be entirely dependent on the patient's mistaken belief in receiving an active drug.

Enjoyed this? Get five picks like this every morning.

Free daily newsletter — zero spam, unsubscribe anytime.

Get the day's top tech discoveries delivered at 6 PM.

Free, source-linked, and easy to unsubscribe from.